Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal Stem Cell Treatment for Steroid RefractoryGraft‐versus‐Host Disease in Children: A Pilot and First Study from Turkey

13 Dec 2015

Abstract excerpt

This study evaluated the efficacy of mesenchymal stem cells (MSCs) from bone marrow of a third-party donor for refractory aGVHD. We report the first experience using MSCs to treat refractory aGVHD in 33 pediatric patients undergoing allogeneic HSCT from Turkey. Totally, 68 doses of bone marrow derived MSCs were infused. The median dose of MSC was 1.18 × 10(6) cells per kg body weight. Overall, complete response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Mesenchymal stem cell research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26783400
DOI: 10.1155/2016/1641402

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal Stem Cell Treatment for Steroid RefractoryGraft‐versus‐Host Disease in Children: A Pilot and First Study from TurkeyPMID 26783400Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft- versus -host disease after haploidentical allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Adult human mesenchymal stromal cells and the treatment of graft versus host diseaseSemantic proximity Read ↗

Graft-versus-host diseaseSemantic proximity Read ↗

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the EvidenceSemantic proximity Read ↗

Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantationSemantic proximity Read ↗

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemiaSemantic proximity Read ↗

Mesenchymal Stromal Cells as Prophylaxis for Graft-versus-host Disease in Haplo-identical Hematopoietic Stem Cell Transplantation Recipients With Severe Aplastic Anemia? - A Systematic Review and Meta-analysisSemantic proximity Read ↗

Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell TransplantationSemantic proximity Read ↗

Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic AnemiaSemantic proximity Read ↗

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.